Medrasa Clinical Research is a clinical research site located in Sherman, Texas, United States 75092.
Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.
Medrasa Clinical Research has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Diabetes Mellitus, Type 2, Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease.
Sponsors: Novo Nordisk A/S, CSL Behring, Philip Morris Products S.A..
Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Medrasa Clinical Research has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Medrasa Clinical Research has 4 clinical trials on record, with 3 currently active. Their work covers Diabetes Mellitus, Type 2, Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease.
Medrasa Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.